LSTM opens $23m robotic AI lab for infection research
The laboratory is expected to open in 2027 and create new jobs in the region.
Drug Development
Novartis India acquires Pfizer brands for $132m
AtomVie opens $160m radiopharmaceutical manufacturing facility in Ontario
FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer
Superluminal Medicines secures $60m to advance rare obesity therapy
Médunik and Biocodex sign exclusive agreement for Diacomit in Canada
Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule
Novartis signs $3.2bn drug delivery deal with Alteogen
